If Jublia (efinaconazole) is not covered for tinea pedis, what is an alternative treatment?

Alternative Treatment for Tinea Pedis When Jublia is Not Covered

Jublia (efinaconazole) is FDA-approved only for onychomycosis (toenail fungus), not tinea pedis (athlete's foot), so you need a different antifungal entirely. 1

First-Line Topical Options

For tinea pedis, topical terbinafine 1% cream applied once daily for 1 week is the preferred treatment, offering superior efficacy with the shortest treatment duration 2. This provides:

• Mycological cure rates comparable to 4 weeks of clotrimazole 1% cream
• Faster clinical resolution than azole alternatives
• Once-daily dosing for better adherence

Alternative Topical Agents

If terbinafine is not available or suitable:

• Ciclopirox olamine 0.77% cream/gel: Apply twice daily for 4 weeks

  • Mycological cure rate ~60% at end of treatment, 85% two weeks post-treatment
  • Superior to clotrimazole 1% cream 2

• Clotrimazole 1% cream: Apply twice daily for 4 weeks

  • Widely available over-the-counter option 2

• Econazole nitrate foam 1%: Apply once daily for 4 weeks

  • Complete cure rate 24.3% vs 3.6% for vehicle
  • Mycological cure rate 67.6%
  • Well-tolerated with superior pruritus relief 3, 4

Oral Therapy Indications

Reserve oral antifungals for:

• Extensive disease
• Failed topical therapy
• Immunocompromised patients
• Concomitant onychomycosis 5, 6

Oral Treatment Options

Oral terbinafine 250 mg once daily for 1 week is the preferred systemic option 2:

• Similar mycological efficacy to itraconazole 100 mg over 2 weeks
• Slightly lower relapse rate
• Well-tolerated in adults and children

Alternative oral agents:

• Itraconazole 100 mg once daily for 2 weeks 2
• Fluconazole: Multiple 150 mg doses (typically 2-4 doses, one week apart) 7
  • 70% of tinea pedis patients required 4 doses
  • Long-term mycological cure 75%

Important Clinical Caveats

Common pitfalls to avoid:

• Do not use combination antifungal-corticosteroid products—these can worsen infection and promote resistance 6
• Terbinafine carries rare risks of neutropenia and liver failure (especially with pre-existing liver disease) 2
• Confirm diagnosis with KOH preparation when possible, as clinical diagnosis accuracy is low 5

Treatment duration matters: Allylamines (terbinafine) achieve high cure rates with 1-week therapy, while azoles require 4 weeks for comparable efficacy 8

Prevention counseling: Advise thorough drying between toes after bathing, daily sock changes, and periodic cleaning of athletic footwear 2